Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 5.10
-1.00 (-16.39%)
Apr 1, 2025, 3:45 PM CET
Arctic Bioscience AS Revenue
Arctic Bioscience AS had revenue of 17.20M NOK in the half year ending June 30, 2024, with 19.46% growth. This brings the company's revenue in the last twelve months to 31.88M, down -18.57% year-over-year. In the year 2023, Arctic Bioscience AS had annual revenue of 33.76M, down -2.07%.
Revenue (ttm)
31.88M
Revenue Growth
-18.57%
P/S Ratio
4.84
Revenue / Employee
1.88M
Employees
355
Market Cap
162.80M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 562.60M |
| Nordhealth AS | 537.23M |
| Photocure ASA | 525.39M |
| Vistin Pharma ASA | 429.50M |
| Hofseth BioCare ASA | 265.54M |
| Omda AS | 426.27M |
| ArcticZymes Technologies ASA | 108.11M |
| Nykode Therapeutics AS | 104.04M |